Structural Imaging Measures of Brain Aging

Samuel N. Lockhart, Charles DeCarli

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

During the course of normal aging, biological changes occur in the brain that are associated with changes in cognitive ability. This review presents data from neuroimaging studies of primarily “normal” or healthy brain aging. As such, we focus on research in unimpaired or nondemented older adults, but also include findings from lifespan studies that include younger and middle aged individuals as well as from populations with prodromal or clinically symptomatic disease such as cerebrovascular or Alzheimer’s disease. This review predominantly addresses structural MRI biomarkers, such as volumetric or thickness measures from anatomical images, and measures of white matter injury and integrity respectively from FLAIR or DTI, and includes complementary data from PET and cognitive or clinical testing as appropriate. The findings reveal highly consistent age-related differences in brain structure, particularly frontal lobe and medial temporal regions that are also accompanied by age-related differences in frontal and medial temporal lobe mediated cognitive abilities. Newer findings also suggest that degeneration of specific white matter tracts such as those passing through the genu and splenium of the corpus callosum may also be related to age-related differences in cognitive performance. Interpretation of these findings, however, must be tempered by the fact that comorbid diseases such as cerebrovascular and Alzheimer’s disease also increase in prevalence with advancing age. As such, this review discusses challenges related to interpretation of current theories of cognitive aging in light of the common occurrence of these later-life diseases. Understanding the differences between “Normal” and “Healthy” brain aging and identifying potential modifiable risk factors for brain aging is critical to inform potential treatments to stall or reverse the effects of brain aging and possibly extend cognitive health for our aging society.

Original languageEnglish (US)
Pages (from-to)271-289
Number of pages19
JournalNeuropsychology Review
Volume24
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Neuroimaging
Brain
Cerebrovascular Disorders
Aptitude
Temporal Lobe
Alzheimer Disease
Corpus Callosum
Frontal Lobe
Biomarkers
Health
Wounds and Injuries
Research
Population
White Matter

Keywords

  • Aging
  • Brain imaging
  • Cognition

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology

Cite this

Structural Imaging Measures of Brain Aging. / Lockhart, Samuel N.; DeCarli, Charles.

In: Neuropsychology Review, Vol. 24, No. 3, 2014, p. 271-289.

Research output: Contribution to journalArticle

Lockhart, Samuel N. ; DeCarli, Charles. / Structural Imaging Measures of Brain Aging. In: Neuropsychology Review. 2014 ; Vol. 24, No. 3. pp. 271-289.
@article{adc45f2a0e7f4958bafabd0a4ba25c60,
title = "Structural Imaging Measures of Brain Aging",
abstract = "During the course of normal aging, biological changes occur in the brain that are associated with changes in cognitive ability. This review presents data from neuroimaging studies of primarily “normal” or healthy brain aging. As such, we focus on research in unimpaired or nondemented older adults, but also include findings from lifespan studies that include younger and middle aged individuals as well as from populations with prodromal or clinically symptomatic disease such as cerebrovascular or Alzheimer’s disease. This review predominantly addresses structural MRI biomarkers, such as volumetric or thickness measures from anatomical images, and measures of white matter injury and integrity respectively from FLAIR or DTI, and includes complementary data from PET and cognitive or clinical testing as appropriate. The findings reveal highly consistent age-related differences in brain structure, particularly frontal lobe and medial temporal regions that are also accompanied by age-related differences in frontal and medial temporal lobe mediated cognitive abilities. Newer findings also suggest that degeneration of specific white matter tracts such as those passing through the genu and splenium of the corpus callosum may also be related to age-related differences in cognitive performance. Interpretation of these findings, however, must be tempered by the fact that comorbid diseases such as cerebrovascular and Alzheimer’s disease also increase in prevalence with advancing age. As such, this review discusses challenges related to interpretation of current theories of cognitive aging in light of the common occurrence of these later-life diseases. Understanding the differences between “Normal” and “Healthy” brain aging and identifying potential modifiable risk factors for brain aging is critical to inform potential treatments to stall or reverse the effects of brain aging and possibly extend cognitive health for our aging society.",
keywords = "Aging, Brain imaging, Cognition",
author = "Lockhart, {Samuel N.} and Charles DeCarli",
year = "2014",
doi = "10.1007/s11065-014-9268-3",
language = "English (US)",
volume = "24",
pages = "271--289",
journal = "Neuropsychology Review",
issn = "1040-7308",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Structural Imaging Measures of Brain Aging

AU - Lockhart, Samuel N.

AU - DeCarli, Charles

PY - 2014

Y1 - 2014

N2 - During the course of normal aging, biological changes occur in the brain that are associated with changes in cognitive ability. This review presents data from neuroimaging studies of primarily “normal” or healthy brain aging. As such, we focus on research in unimpaired or nondemented older adults, but also include findings from lifespan studies that include younger and middle aged individuals as well as from populations with prodromal or clinically symptomatic disease such as cerebrovascular or Alzheimer’s disease. This review predominantly addresses structural MRI biomarkers, such as volumetric or thickness measures from anatomical images, and measures of white matter injury and integrity respectively from FLAIR or DTI, and includes complementary data from PET and cognitive or clinical testing as appropriate. The findings reveal highly consistent age-related differences in brain structure, particularly frontal lobe and medial temporal regions that are also accompanied by age-related differences in frontal and medial temporal lobe mediated cognitive abilities. Newer findings also suggest that degeneration of specific white matter tracts such as those passing through the genu and splenium of the corpus callosum may also be related to age-related differences in cognitive performance. Interpretation of these findings, however, must be tempered by the fact that comorbid diseases such as cerebrovascular and Alzheimer’s disease also increase in prevalence with advancing age. As such, this review discusses challenges related to interpretation of current theories of cognitive aging in light of the common occurrence of these later-life diseases. Understanding the differences between “Normal” and “Healthy” brain aging and identifying potential modifiable risk factors for brain aging is critical to inform potential treatments to stall or reverse the effects of brain aging and possibly extend cognitive health for our aging society.

AB - During the course of normal aging, biological changes occur in the brain that are associated with changes in cognitive ability. This review presents data from neuroimaging studies of primarily “normal” or healthy brain aging. As such, we focus on research in unimpaired or nondemented older adults, but also include findings from lifespan studies that include younger and middle aged individuals as well as from populations with prodromal or clinically symptomatic disease such as cerebrovascular or Alzheimer’s disease. This review predominantly addresses structural MRI biomarkers, such as volumetric or thickness measures from anatomical images, and measures of white matter injury and integrity respectively from FLAIR or DTI, and includes complementary data from PET and cognitive or clinical testing as appropriate. The findings reveal highly consistent age-related differences in brain structure, particularly frontal lobe and medial temporal regions that are also accompanied by age-related differences in frontal and medial temporal lobe mediated cognitive abilities. Newer findings also suggest that degeneration of specific white matter tracts such as those passing through the genu and splenium of the corpus callosum may also be related to age-related differences in cognitive performance. Interpretation of these findings, however, must be tempered by the fact that comorbid diseases such as cerebrovascular and Alzheimer’s disease also increase in prevalence with advancing age. As such, this review discusses challenges related to interpretation of current theories of cognitive aging in light of the common occurrence of these later-life diseases. Understanding the differences between “Normal” and “Healthy” brain aging and identifying potential modifiable risk factors for brain aging is critical to inform potential treatments to stall or reverse the effects of brain aging and possibly extend cognitive health for our aging society.

KW - Aging

KW - Brain imaging

KW - Cognition

UR - http://www.scopus.com/inward/record.url?scp=84919948361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919948361&partnerID=8YFLogxK

U2 - 10.1007/s11065-014-9268-3

DO - 10.1007/s11065-014-9268-3

M3 - Article

C2 - 25146995

AN - SCOPUS:84919948361

VL - 24

SP - 271

EP - 289

JO - Neuropsychology Review

JF - Neuropsychology Review

SN - 1040-7308

IS - 3

ER -